Introduction: A to Z multivitamin formulations, are widely prescribed to address nutritional deficiencies and support overall health across various patient populations. Despite their common use, data on physicians’ perspectives regarding their clinical utilization is limited. This study aimed to explore prescribing patterns, perceived benefits, and physicians’ attitudes and opinions toward A to Z multivitamin formulations. Methods: A nationwide, multicentre, cross-sectional study was conducted using a structured questionnaire. Physicians from specialties including paediatrics, general practice, and internal medicine were studied across multiple centres. The questionnaire assessed opinions, perceptions, and attitudes toward A to Z multivitamin formulations in both tablet and syrup forms. Results: In the interim analysis, responses from 6,095 healthcare professionals (HCPs) were included, with 3325 (54.5%) being general practitioners followed by 1459 (23.9%) paediatricians and 1313 (21.5%) physicians/ surgeons. The majority of 5554 (91.1%) HCPs regularly prescribed A to Z formulations most often due to nutritional deficiency 2947 (48.4%) and general well-being (45.9%). A significant number of 5406 (88.7%) of HCPs rated these formulations as highly effective, and 5640 (92.5%) reported no adverse events during usage. Additionally, 4695 (77%) considered them cost-effective compared to other multivitamins, and 5053 (82.9%) noted high patient compliance. Most of the HCPs, about 4695 (77%) also believed A to Z products play a definitive role in managing chronic diseases as well. Conclusion: The study provides valuable insights into the widespread acceptance of A to Z multivitamin formulations as effective, safe, and cost-effective options for various patient populations. These findings can inform future clinical recommendations and strategies for multivitamin supplementation.

Introduction: A to Z multivitamin formulations, are widely prescribed to address nutritional deficiencies and support overall health across various patient populations. Despite their common use, data on physicians’ perspectives regarding their clinical utilization is limited. This study aimed to explore prescribing patterns, perceived benefits, and physicians’ attitudes and opinions toward A to Z multivitamin formulations. Methods: A nationwide, multicentre, cross-sectional study was conducted using a structured questionnaire. Physicians from specialties including paediatrics, general practice, and internal medicine were studied across multiple centres. The questionnaire assessed opinions, perceptions, and attitudes toward A to Z multivitamin formulations in both tablet and syrup forms. Results: In the interim analysis, responses from 6,095 healthcare professionals (HCPs) were included, with 3325 (54.5%) being general practitioners followed by 1459 (23.9%) paediatricians and 1313 (21.5%) physicians/ surgeons. The majority of 5554 (91.1%) HCPs regularly prescribed A to Z formulations most often due to nutritional deficiency 2947 (48.4%) and general well-being (45.9%). A significant number of 5406 (88.7%) of HCPs rated these formulations as highly effective, and 5640 (92.5%) reported no adverse events during usage. Additionally, 4695 (77%) considered them cost-effective compared to other multivitamins, and 5053 (82.9%) noted high patient compliance. Most of the HCPs, about 4695 (77%) also believed A to Z products play a definitive role in managing chronic diseases as well. Conclusion: The study provides valuable insights into the widespread acceptance of A to Z multivitamin formulations as effective, safe, and cost-effective options for various patient populations. These findings can inform future clinical recommendations and strategies for multivitamin supplementation.